name:-0.0027780532836914
name:-0.036566972732544
name:-0.002769947052002
Knoll Aktiengesellschaft Patent Filings

Knoll Aktiengesellschaft

Patent Applications and Registrations

Patent applications and USPTO patent grants for Knoll Aktiengesellschaft.The latest application filed is for "use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6".

Company Profile
0.32.1
  • Knoll Aktiengesellschaft - Ludwigshafen DE
  • Knoll Aktiengesellschaft - DE DE
  • Knoll Aktiengesellschaft - Rheinland Pfalz DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Medical treatment
Grant 6,617,360 - Bailey , et al. September 9, 2
2003-09-09
Method for producing atropic acid ethyl ester
Grant 6,509,493 - Falkenberg , et al. January 21, 2
2003-01-21
Liquid pharmaceutical compositions comprising thyroid hormones
Grant 6,458,842 - Dickinson , et al. October 1, 2
2002-10-01
Tetracycline-inducible transcriptional inhibitor fusion proteins
Grant 6,271,348 - Bujard , et al. August 7, 2
2001-08-07
Use of anti-TNF antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6
App 20010010819 - Stenzel, Roswitha ;   et al.
2001-08-02
Transgenic organisms having tetracycline-regulated transcriptional regulatory systems
Grant 6,252,136 - Bujard , et al. June 26, 2
2001-06-26
Use of anti-TNF antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6
Grant 6,235,281 - Stenzel , et al. May 22, 2
2001-05-22
Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
Grant 6,218,405 - Birch , et al. April 17, 2
2001-04-17
Method of purifying thrombin-like protease enzymes obtained from snake venom
Grant 6,200,791 - Schwarz , et al. March 13, 2
2001-03-13
Method for combating obesity
Grant 6,197,780 - Munter , et al. March 6, 2
2001-03-06
Particles with modified physicochemical properties, their preparation and uses
Grant 6,197,349 - Westesen , et al. March 6, 2
2001-03-06
Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use
Grant 6,187,802 - Cheetham , et al. February 13, 2
2001-02-13
Defined enzyme mixtures for obtaining cells and treating wounds
Grant 6,146,626 - Markert , et al. November 14, 2
2000-11-14
Piperazine derivatives as therapeutic agents
Grant 6,114,334 - Kerrigan , et al. September 5, 2
2000-09-05
Heteroarylcarboxamide derivatives for treating CNS disorders
Grant 6,107,310 - Birch , et al. August 22, 2
2000-08-22
Heterocyclcarboxamide derivatives and their use as therapeutic agents
Grant 5,935,973 - Birch , et al. August 10, 1
1999-08-10
1,2,4-triazolo[4,3-b]pyridazine derivatives and their use
Grant 5,905,079 - Sargent , et al. May 18, 1
1999-05-18
Methods for regulating gene expression
Grant 5,888,981 - Bujard , et al. March 30, 1
1999-03-30
Pharmaceutical compositions
Grant 5,877,175 - Sargent , et al. March 2, 1
1999-03-02
Preparation of selegiline
Grant 5,847,216 - Ott-Dembrowski , et al. December 8, 1
1998-12-08
Therapeutic agents
Grant 5,804,586 - Sargent , et al. September 8, 1
1998-09-08
Condensed 4-aminopyridines with antirheumatic activity
Grant 5,780,482 - Armitage , et al. July 14, 1
1998-07-14
Therapeutic agents
Grant 5,753,665 - Sargent , et al. May 19, 1
1998-05-19
Therapeutic agents containing thyroid hormones
Grant 5,753,254 - Khan , et al. May 19, 1
1998-05-19
Dihydrodibenzisoquinolinediones
Grant 5,703,089 - Brana , et al. December 30, 1
1997-12-30
Tetracycline-inducible transcriptional activator and tetracycline-regulated transcription units
Grant 5,654,168 - Bujard , et al.
1997-08-05
Therapeutic agents
Grant 5,652,271 - Harris , et al. July 29, 1
1997-07-29
Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
Grant 5,650,298 - Bujard , et al.
1997-07-22
Tetracycline regulated transcriptional modulators with altered DNA binding specificities
Grant 5,589,362 - Bujard , et al. Dec
1996-12-31
Asymmetrically substituted bisnaphthalimides
Grant 5,554,622 - Bra na , et al. September 10, 1
1996-09-10
Stable emulsion suitable for pharmaceutical administration, the production thereof and emulsion for pharmaceutical use
Grant 5,496,818 - Schaupp , et al. March 5, 1
1996-03-05
Resolution of racemic verapamil
Grant 5,457,224 - Ehrmann , et al. October 10, 1
1995-10-10
Resolution of 5-methyltetrahydrofolic acid
Grant 5,457,202 - Scheib , et al. October 10, 1
1995-10-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed